{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T11:40:35Z","timestamp":1718106035283},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s13277-015-4087-6","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T07:14:22Z","timestamp":1443251662000},"page":"2879-2890","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker"],"prefix":"10.1007","volume":"37","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"issue":"1","key":"4087_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"4087_CR2","first-page":"305","volume":"7","author":"I Alkatout","year":"2015","unstructured":"Alkatout I, Schubert M, Garbrecht N, Weigel MT, Jonat W, Mundhenke C, et al. Vulvar cancer: epidemiology, clinical presentation, and management options. J Women\u2019s Health. 2015;7:305\u201313.","journal-title":"J Women\u2019s Health"},{"issue":"3","key":"4087_CR3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ygyno.2013.11.025","volume":"132","author":"CJ Reade","year":"2014","unstructured":"Reade CJ, Eiriksson LR, Mackay H. Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecol Oncol. 2014;132(3):780\u20139.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4087_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3760\/cma.j.issn.0366-6999.20110738","volume":"126","author":"L Ma","year":"2013","unstructured":"Ma L, Liu YP, Zhang XH, Geng CZ, Li ZH. Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients. Chin Med J. 2013;126(2):242\u20137.","journal-title":"Chin Med J"},{"issue":"11","key":"4087_CR5","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1080\/09168451.2014.943650","volume":"78","author":"X Liu","year":"2014","unstructured":"Liu X, Chen D, Liu G. Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells. Biosci Biotechnol Biochem. 2014;78(11):1895\u2013901.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"5","key":"4087_CR6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1210\/me.2011-1130","volume":"26","author":"LJ Schmidt","year":"2012","unstructured":"Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, et al. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Mol Endocrinol. 2012;26(5):716\u201335.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"4087_CR7","first-page":"3724","volume":"7","author":"D Zhang","year":"2014","unstructured":"Zhang D, Zhang JY, Dai SD, Liu SL, Liu Y, Tang N, et al. Co-expression of delta-catenin and RhoA is significantly associated with a malignant lung cancer phenotype. Int J Clin Exp Pathol. 2014;7(7):3724\u201332.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5350","key":"4087_CR8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.279.5350.509","volume":"279","author":"A Hall","year":"1998","unstructured":"Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279(5350):509\u201314.","journal-title":"Science"},{"issue":"3","key":"4087_CR9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jmi.12025","volume":"251","author":"AJ Ridley","year":"2013","unstructured":"Ridley AJ. RhoA, RhoB and RhoC have different roles in cancer cell migration. J Microsc. 2013;251(3):242\u20139.","journal-title":"J Microsc"},{"issue":"3","key":"4087_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4161\/sgtp.25131","volume":"4","author":"K O\u2019Connor","year":"2013","unstructured":"O\u2019Connor K, Chen M. Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases. 2013;4(3):141\u20137.","journal-title":"Small GTPases"},{"key":"4087_CR11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2741\/3830","volume":"16","author":"AP Struckhoff","year":"2011","unstructured":"Struckhoff AP, Rana MK, Worthylake RA. RhoA can lead the way in tumor cell invasion and metastasis. Front Biosci (Landmark Ed). 2011;16:1915\u201326.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"4087_CR12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1096-9896(199605)179:1<74::AID-PATH531>3.0.CO;2-E","volume":"179","author":"J Mathew","year":"1996","unstructured":"Mathew J, Hines JE, Obafunwa JO, Burr AW, Toole K, Burt AD. CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol. 1996;179(1):74\u20139.","journal-title":"J Pathol"},{"key":"4087_CR13","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1038\/ncomms6458","volume":"5","author":"P Rodrigues","year":"2014","unstructured":"Rodrigues P, Macaya I, Bazzocco S, Mazzolini R, Andretta E, Dopeso H, et al. RHOA inactivation enhances Wnt signalling and promotes colorectal cancer. Nat Commun. 2014;5:5458.","journal-title":"Nat Commun"},{"issue":"6","key":"4087_CR14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/jcb.24480","volume":"114","author":"KD Fagan-Solis","year":"2013","unstructured":"Fagan-Solis KD, Schneider SS, Pentecost BT, Bentley BA, Otis CN, Gierthy JF, et al. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line. J Cell Biochem. 2013;114(6):1385\u201394.","journal-title":"J Cell Biochem"},{"issue":"1","key":"4087_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oraloncology.2012.07.003","volume":"49","author":"KW Chang","year":"2013","unstructured":"Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ, et al. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol. 2013;49(1):27\u201333.","journal-title":"Oral Oncol"},{"issue":"11","key":"4087_CR16","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.3390\/toxins5112241","volume":"5","author":"A Augspach","year":"2013","unstructured":"Augspach A, List JH, Wolf P, Bielek H, Schwan C, Els\u00e4sser-Beile U, et al. Activation of RhoA, B, C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cells. Toxins (Basel). 2013;5(11):2241\u201357.","journal-title":"Toxins (Basel)"},{"issue":"120","key":"4087_CR17","first-page":"2523","volume":"59","author":"XT Xu","year":"2012","unstructured":"Xu XT, Song QB, Yao Y, Ruan P, Tao ZZ. Inhibition of RhoA\/ROCK signaling pathway promotes the apoptosis of gastric cancer cells. Hepato-Gastroenterology. 2012;59(120):2523\u20136.","journal-title":"Hepato-Gastroenterology"},{"key":"4087_CR18","doi-asserted-by":"crossref","unstructured":"Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Li AF, et al. The correlation between RhoA expression and clinicopathological characteristics in gastric cancer patients after curative surgery. World J Surg. 2015.","DOI":"10.1007\/s00268-015-3095-4"},{"issue":"8","key":"4087_CR19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/abbs\/gmu051","volume":"46","author":"G Yan","year":"2014","unstructured":"Yan G, Zou R, Chen Z, Fan B, Wang Z, Wang Y, et al. Silencing RhoA inhibits migration and invasion through Wnt\/\u03b2-catenin pathway and growth through cell cycle regulation in human tongue cancer. Acta Biochim Biophys Sin. 2014;46(8):682\u201390.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"2","key":"4087_CR20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3892\/or.2015.4009","volume":"34","author":"X Wang","year":"2015","unstructured":"Wang X, Jiang W, Kang J, Liu Q, Nie M. Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice. Oncol Rep. 2015;34(2):891\u20139.","journal-title":"Oncol Rep"},{"issue":"12","key":"4087_CR21","doi-asserted-by":"crossref","first-page":"24187","DOI":"10.3390\/ijms141224187","volume":"14","author":"S Chen","year":"2013","unstructured":"Chen S, Wang J, Gou WF, Xiu YL, Zheng HC, Zong ZH, et al. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma. Int J Mol Sci. 2013;14(12):24187\u201399.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4087_CR22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1677\/erc.1.01012","volume":"12","author":"WB Zhong","year":"2005","unstructured":"Zhong WB, Liang YC, Wang CY, Chang TC, Lee WS. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA\/ROCK signaling. Endocr Relat Cancer. 2005;12(3):615\u201329.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"4087_CR23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/01443611003605302","volume":"30","author":"N Suzuki","year":"2010","unstructured":"Suzuki N, Imai A. HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A. J Obstet Gynaecol. 2010;30(4):404\u20137.","journal-title":"J Obstet Gynaecol"},{"issue":"12","key":"4087_CR24","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1349-7006.2008.00977.x","volume":"99","author":"A Oriuchi","year":"2008","unstructured":"Oriuchi A, Kikuchi N, Osada R, Wang C, Hayashi A, Nikaido T, et al. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer. Cancer Sci. 2008;99(12):2532\u20139.","journal-title":"Cancer Sci"},{"issue":"33","key":"4087_CR25","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/onc.2010.219","volume":"29","author":"TT Zhao","year":"2010","unstructured":"Zhao TT, Le Francois BG, Goss G, Ding K, Bradbury PA, Dimitroulakos J. Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins. Oncogene. 2010;29(33):4682\u201392.","journal-title":"Oncogene"},{"issue":"3","key":"4087_CR26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bbrc.2005.11.075","volume":"339","author":"J Lee","year":"2006","unstructured":"Lee J, Lee I, Park C, Kang WK. Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells. Biochem Biophys Res Commun. 2006;339(3):748\u201354.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4087-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4087-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4087-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4087-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T11:27:40Z","timestamp":1718105260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4087-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,26]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["4087"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4087-6","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,26]]}}}